Use of the chelating agent edathamil disodium in acrosclerosis, sarcoidosis and other skin conditions with comments on tryptophan metabolism in sarcoidosis.
D002614:Chelating Agents; D004492:Edetic Acid / Q000628:therapy*; D012507:Sarcoidosis / Q000628:therapy*; D012594:Scleroderma, Localized; D012871:Skin Diseases; D014364:Tryptophan / Q000378:metabolism*
D002614:Chelating Agents; D014364:Tryptophan; D004492:Edetic Acid
EDATHAMIL/therapy; SARCOIDOSIS/therapy; SKIN/diseases; TRYPTOPHAN/metabolism